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Abstract
Background: There is some evidence that ATP binding cassette (ABC) transporters play a role in resistance to
anthelmintics, particularly against macrocyclic lactones. Some anthelmintics, including ivermectin (IVM), have been
shown to induce transcription of multiple ABC transporters in nematodes; however, the effects of monepantel
(MPL) on transcription of these transporter genes has not been studied.
Methods: Larvae of two MPL-susceptible isolates of Haemonchus contortus were exposed to MPL at two
concentrations (2.5 and 250 μg/ml) for periods of 3, 6 and 24 h. Transcription levels of sixteen ABC transporter
genes were measured at the end of the incubation periods. The consequences of MPL exposure were
examined by measuring rhodamine-123 efflux from the larvae, and their sensitivity to subsequent treatment
with IVM or levamisole.
Results: Multiple ABC transporter genes showed significantly higher transcription in both worm isolates
following exposure to MPL at 250 μg/ml for 3, 6 or 24 h, particularly the P-glycoprotein (P-gp) genes pgp-11,
pgp-12 and pgp-14. Of these, only pgp-11 maintained the elevated levels 24 h after the end of the drug
exposure period. In contrast, there was only a single instance of low-level upregulation as a result of exposure
to MPL at 2.5 μg/ml. Larvae exposed to MPL at 250 μg/ml showed an increased efflux of rhodamine-123 and a
proportion of the larval population showed an ability to subsequently tolerate higher concentrations of IVM in
migration assays. There was no increased tolerance to IVM following pre-exposure to MPL at 2.5 μg/ml.
Conclusions: Exposure of H. contortus larvae to 250 μg/ml MPL results in increased transcription of multiple
transporter genes and increased R-123 efflux. The subsequent ability of a proportion of the larvae to tolerate
IVM suggests a protective role of ABC transporters across different chemical entities. However, these
observations were only made at a concentration of MPL well above that experienced by parasitic life stages in
vivo, and hence their significance remains unclear.
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Background
Monepantel (MPL) (trade name Zolvix®) was the first
new anthelmintic for livestock use for over 25 years
when it appeared in 2009. It was first introduced in New
Zealand for the control of gastrointestinal nematodes
(GINs) and associated diseases in small ruminants, and
later in Australia and the United Kingdom in 2010. It
shows broad-spectrum anthelmintic activity, targeting
larval and adult stages of the most important species of
sheep GINs [1, 2]. The compound is an amino-acetonitrile
derivative (AAD) that acts as a positive allosteric modula-
tor of a nematode-specific clade of nicotinic acetylcholine
receptor (nAChR) subunits. Genetic screening of Cae-
norhabditis elegans revealed nAChR subunit ACR-23
as a target for MPL action [2], while Rufener et al. [3]
suggested that Hco-MPTL-1 and other nAChR sub-
units of the DEG-3 subfamily are the targets for MPL
in H. contortus.
Resistance to MPL was first reported by Scott et al. [4]
in New Zealand. The authors reported that MPL showed
no efficacy in terms of egg count reduction in goats or
reduction of worm burden in sheep, and was ineffective
against at least two GINs (Teladorsagia circumcincta
and Trichostrongylus colubriformis). There is also evi-
dence of MPL resistance in Teladorsagia spp. and T.
colubriformis on a goat farm in New South Wales,
Australia [5]. Resistance to MPL has also been reported
in H. contortus in Uruguay, where the authors reported
poor efficacy against this nematode with 42 and 82 %
faecal egg count reduction at two different sheep farms
[6]. A more recent study has also reported H. contortus
population resistant to MPL at a sheep farm in
Netherlands [7]. Early work on MPL resistance in
laboratory-selected isolates of H. contortus showed that
the resistance was associated with a number of changes
to the target site. These mutations resulted in the gener-
ation of various truncated versions of the target receptor
that would be expected to be non-functional [3]. How-
ever, there is no information at present on whether such
target site changes are involved in any of the cases of
resistance reported from the field. We were interested in
whether ABC transporters may interact with MPL in
nematodes, as a number of anthelmintics are known to
be substrates of these transporters, and increases in
efflux activity are associated with anthelmintic resistance
in some cases, particularly for macrocyclic lactones [8–10].
As AAD compounds are hydrophobic, they may also be
substrates for the drug transport proteins [11].
There is a considerable evidence that exposure to
anthelmintics results in increased transcription of some
ABC transporter genes, both in vitro [11–14] and in vivo
[15–17]. These studies have generally concluded that
such a transcriptional response suggests a role for the
transporters in the efflux of the transcription-inducing
anthelmintic, that is, the anthelmintic is likely a sub-
strate for the transporters. Therefore, as a first step in
understanding the interaction of efflux pathways with
MPL in nematodes, the present study aimed to explore
the effects of MPL exposure on the transcription pat-
terns of ABC transporters in third-stage larvae (L3) of
two MPL-susceptible isolates of H. contortus. We further
investigated the phenotypic effects of this drug exposure
by (i) measuring the efflux of the fluorescent dye
rhodamine-123 (R-123) from the L3 pre-exposed to
MPL compared to controls, and (ii) examining whether
MPL pre-exposure enabled the L3 to tolerate subsequent




Two isolates of H. contortus were used in the present
study: (i) Kirby, a drug susceptible isolate recovered from
the field at the University of New England, Kirby
Research Farm in 1986 [18]; and (ii) Wallangra (WAL), a
multi-drug resistant isolate collected from the New
England region of New South Wales (NSW) in 2003; at
the time of isolation, it was resistant to benzimidazole,
closantel, LEV, IVM and moxidectin [19]. The isolate
has been further selected over at least five generations
with moxidectin (Cydectin®) and is now unaffected by
the recommended dose of moxidectin.
Both isolates were recovered from the field before
the introduction of MPL, and show equivalent sensi-
tivity to this drug in larval development assays [20].
Infected animals were housed at the Commonwealth
Scientific and Industrial Research Organisation
(CSIRO) Agriculture and Food FD McMaster labora-
tory at Armidale, NSW. Faeces were collected from
infected animals and sent to the CSIRO Agriculture
laboratories at the Queensland Bioscience Precinct,
Brisbane, QLD, in zip-lock bags. Third-stage larvae
(L3) were harvested from faecal cultures held at 27 °C
for 7 days. The L3 were stored at 15 °C, and used for
experiments within 4 weeks.
In vitro monepantel exposure
The commercially available drench product Zolvix®
(Novartis Animal Health, Australia) (25 mg MPL/ml)
was used as a source of MPL in this study. Multiple
separate anthelmintic solutions were prepared by two-
fold serial dilutions in dimethyl-sulfoxide (DMSO).
Groups of approximately 30,000 L3 of each isolate
were exposed to two concentrations of MPL (2.5 μg/ml
and 250 μg/ml) and DMSO (vehicle control) for a range
of time periods (3, 6 and 24 h). The DMSO concentration
was 1 % (v/v) across all samples. The MPL concentrations
were chosen based on:
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(i) 250 μg/ml: the highest concentration that L3
could be exposed to while maintaining an ability
to migrate at equivalent levels to controls in
subsequent migration assays, that is, the highest
concentration that could be used without
compromising the fitness of the larvae as
measured by migration assays (migration at
250 μg/ml approximately 90 % of controls)
(unpublished data); and
(ii)2.5 μg/ml: as an approximation of the range of MPL
concentrations of 2–4 μg/g measured by Lifschitz et
al. [21] in the abomasal contents of sheep within the
first 48 h following administration of Zolvix®.
The larvae were kept on a roller-mixer (BTR-5, Ratek,
Boronia, Australia) for the entire duration of the drug-
exposure period. Three separate experiments were
performed. At the end of the incubation period, larvae
were processed in two ways:
(i) For use in RNA extraction, larvae were centrifuged
(3000× g, 1 min), and the pellets were washed with
1 ml water, centrifuged again (3000× g, 1 min), and
the pelleted L3 were stored at -80 °C.
(ii)For use in R-123 and migration assays, larvae were
centrifuged (3000× g, 1 min), and the pellets were
washed with 1 ml water, centrifuged again (3000× g,
1 min), and the L3 were resuspended in water and
used immediately.
qPCR analysis
RNA extraction, cDNA synthesis and qPCR were per-
formed as described by Raza et al. [13]. Briefly, total
RNA was extracted from 30,000 L3 using the RNeasy
mini kit (Qiagen, Hilden, Germany) as recommended by
the manufacturer. Turbo-DNase (Ambion, Carlsbad,
USA) was used to remove genomic DNA. cDNA was
synthesized using DNase-treated RNA with superscript
III reverse transcriptase (Invitrogen, Carlsbad, USA)
according to the manufacturer’s instructions. The cDNA
samples were diluted to a concentration of 4 ng/ml for
downstream applications.
The primers used in this study for quantitative PCR of
11 pgp genes, two multidrug-resistance protein genes
(mrp-1 and mrp-5), two genes from the ABCF famil-
y(abcf-1 and abcf-2) and one half transporter gene (haf-
6) were as reported by Raza et al. [13]. Three housekeep-
ing genes (GAPDH, actin and β-tubulin) were used as
reference genes for the qPCR analysis (see Additional
file 1: Table S1). The SYBR Green dye system (Applied
Biosystems, Warrington, UK) was used in a Vii A7 ther-
mocycler (Applied Biosystems, USA) under the follow-
ing PCR cycling conditions: 50 °C for 2 min, 95 °C for
10 min (stage I), followed by 40 cycles of 95 °C for 15 s,
60 °C for 1 min (stage II) and a melt curve stage at
95 °C for 15 s, 60 °C for 1 min and 95 °C for 15 s
(stage III). Three separate extractions for each treat-
ment were examined, with each PCR run in quadrupli-
cate. Reaction efficiencies, determined by standard
curves, were in the range between 80 and 99 %. The
homogeneity of the PCR products was ensured by (i)
analysing the melt-curves in each run, (ii) visualizing a
single band for each PCR product on 2 % electrop-
horesis gels, and (iii) cloning of the selected primer
products into the vector PCR2.1 (Invitrogen, USA)
followed by sequencing (Big-Dye terminator, V3.1;
Applied Biosystems, USA) using M13 forward/reverse
primers. Expression values for all genes in each sample
were normalised to the housekeeping genes using
REST 2009 (version v2.0.13) to determine the effects
of MPL pre-exposure on the transcription of ABC
transporters (drug exposure regimen described above)
using DMSO treated samples as control for each iso-
late. The triplicate expression values were log10 trans-
formed and analysed using repeated measures ANOVA
with Fischer’s Least Significant Difference (LSD) post-
hoc test (P < 0.05) to compare the transcription profiles
of control and MPL-exposed samples in GraphPad
Prism(version 6.01).
Rhodamine (R-123) efflux assay
R-123 efflux was measured in order to determine the
effects of MPL pre-exposure (2.5 μg/ml and 250 μg/ml)
on the efflux activity of ABC transporters in Kirby and
WAL L3stage larvae, using the protocols described earl-
ier [13]. Briefly, approximately 20,000 L3 were exposed
to MPL or DMSO for 3 and 6 h (as described above)
and then placed into a solution of R-123 (2 ml of
1.5 μM) for 15 min in the dark at room temperature on
a roller-mixer. The worms were centrifuged (3000× g,
1 min) and washed with 1 ml of distilled water. The pel-
let was resuspended in distilled water (1 ml) and placed
on a roller for 60 min in the dark. Finally, the worms
were centrifuged (3000× g, 1 min) and the supernatant
was collected and stored in dark for 60 min before use.
R-123 concentration in the supernatant was detected
by measuring the specific fluorescence (λ for excita-
tion = 495 nm and λ for emission = 525 nm) using a
spectrophotometer (Spectra Max M3, Molecular Devices®,
Sunnyvale, CA, USA). The concentration of R-123 in each
experimental sample was calculated from a standard
curve, determined using a range of R-123 concentrations.
Each experiment consisted of duplicate incubations for
each treatment. Three separate experiments were
performed and data (n = 3 for each treatment) were
log10-transformed and analysed using repeated mea-
sures ANOVA followed by Fischer’s LSD test (P < 0.05)
(GraphPad Prism, version 6.01).
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Larval migration assay (LMA)
LMAs were used to measure the changes in tolerance of
Kirby and WAL L3 to IVM and LEV following pre-
exposure to MPL for 3 or 6 h. We were unable to assess
whether MPL pre-exposure resulted in tolerance to
MPL itself as this drug does not inhibit larval migration,
even at high concentrations, and is therefore not suitable
for use in LMAs [20]. The assay was performed follow-
ing the procedure as reported by Raza et al. [13]. This
method was based on that described earlier by Kotze et
al. [22], except with the drug exposure and migration pe-
riods reduced from 24–48 h to 30 min each in order to
allow for assessment of migration inhibition without
providing any time for drug-induced gene expression
changes to occur during the time course of the migra-
tion assay itself.
Briefly, MPL pre-treated (2.5 μg/ml and 250 μg/ml) or
control (pre-exposure to 1 % DMSO only) larvae
(3800 L3/ ml of water) were exposed to a range of IVM
and LEV concentrations in 96-well microtiter plates for
30 min at 27 °C. Final concentrations for IVM and LEV
ranged from 100-0.195 μg/ml and 12.5–0.024 μg/ml,
respectively. After 30 min, the larvae were collected
using a multi-tip pipette and placed into migration
plates with 20 μm filters above receiver plate wells
(Millipore, Bayswater, Australia). The larvae were allowed
to migrate through the filters for a period of 30 min, be-
fore the filter plates were removed and the larvae in the
receiver wells killed using Lugol’s iodine, and counted.
Migration assays consisted of triplicate assay wells at
each IVM or LEV concentration. Three separate experi-
ments were performed for each isolate. Data were ana-
lysed using non-linear regression in GraphPad Prism
(version 6.01). IC50 values and 95 % confidence intervals
were calculated based on the pooled data from each set
of nine assays, and significant differences were deter-
mined by the overlap of 95 % confidence intervals.
The dose response to IVM in the short-term migration
assays used in the present study showed the presence of
a plateau in the response at the highest drug concentra-
tions, as described previously by Raza et al. [13]. The
percent migration remained at a constant level (above
0 %) over the highest 2 to 3 drug concentrations. Hence,
for the analysis of the IVM dose-response data, we used
a non-normalised model in GraphPad (‘top to bottom’),
with a variable slope. The output of this analysis pro-
vided us with two parameters with which to compare
populations: first, the percent migration at the dose-
response plateau (that is, the percentage of the popula-
tion unaffected by the highest concentrations of IVM in
the assay), and secondly, the IC50 in the remaining pro-
portion of the population that had shown a dose-
response to the drug (for instance, if the plateau existed
at a level of 30 % migration, then the IC50 value defined
the response to the drug in the remaining 70 % of the
worm population alone). In addition, to further deter-
mine the significant differences between the percentage
of larval migration following exposure to DMSO and
MPL, the percent migration in MPL-pre-exposed com-
pared to DMSO-pre-exposed worms at each IVM con-
centration were compared using a t-test with Welch’s
correction (P < 0.05) (GraphPad Prism).
Results
Transcriptional response of ABC transporters to MPL
exposure in Kirby larvae
Figure 1 shows the transcription patterns of ABC trans-
porters following exposure of Kirby L3 to MPL at
2.5 μg/ml (panels a, b and c) or 250 μg/ml (panels d, e
and f) for 3, 6 and 24 h, relative to control larvae (exposed
to DMSO only). The fold changes in expression levels in re-
sponse to 250 μg/ml MPL (relative to DMSO-treated con-
trols) are shown in Table 1. There were instances of
increased and decreased expression of transporter genes
across the various time points in MPL-treated L3 compared
to controls, with more instances of increased rather than
decreased expression levels, and with increases being gener-
ally of a greater magnitude (fold change) than the decreases
(ANOVA: 2.5 μg/ml, 3 h F(16,32) = 3.227, P = 0.0023, 6 h
F(16,32) = 1.070, P = 0.4191, 24 h F(16,32) = 2.509, P = 0.0131;
250 μg/ml, 3 h F(16,32) = 5.224, P < 0.0001, 6 h F(16,32) =
3.037, P = 0.0036, 24 h F(16,32) = 69.82, P < 0.0001). The tran-
scriptional responses to MPL250 μg/ml were greater than for
MPL2.5 μg/ml, in terms of both the number of significant
changes, and their magnitude. The only instance of sig-
nificant gene upregulation following treatment with
MPL2.5 μg/ml was a 1.7-fold increase in transcription
level of pgp-11 (P = 0.002) at 3 h (Fig. 1a). There were
no significant changes in transcription patterns of any
of the transporter genes after 6 h exposure to MPL2.5
μg/ml (Fig. 1b); whereas, after 24 h exposure, there was
significant downregulation of pgp-9.1 (1.5-fold; P = 0.01)
and pgp-11 (1.6-fold; P = 0.007) (Fig. 1c).
Following exposure to MPL250 μg/ml for 3 and 6 h, pgp-
12 transcription was increased by 5.4-fold (P = 0.007)
and 9.1-fold (P = 0.002), respectively, while pgp-14
showed 8.7-fold (P = 0.002) and 4.6-fold (P = 0.03)
increases, respectively (Fig. 1d, e) (Table 1). Exposure to
MPL250 μg/ml for 3 h resulted in significant downre-
gulation of pgp-2 and haf-6 by 3.4-fold (P = 0.002) and
1.7-fold (P = 0.02), respectively. These decreases in tran-
scription were short-lived, as, by 6 h, transcription levels
for these two genes had returned to levels equivalent to
DMSO-controls (Fig. 1d, e). Four P-gp genes and mrp-1
were significantly upregulated (P < 0.0001) following
24 h exposure to MPL250 μg/ml; the increases were as
follows: 8.8-fold for pgp-11, 2.4-fold for pgp-14, 2.3-fold
for pgp-12, 2.2-fold for pgp-2 and 1.8-fold for mrp-1. In
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addition, there were some instances of downregula-
tion, with pgp-10 (1.6-fold, P < 0.0001), pgp-16 (2-fold,
P < 0.0001) and mrp-5 (1.4-fold, P = 0.009) showing
significantly decreased transcriptions relative to
DMSO controls (Fig. 1f ) (Table 1). The most consist-
ent changes in larval gene expression following expos-
ure to MPL250 μg/ml were the increased transcription
of pgp-12 and pgp-14 at each of the three time
points. There was a single instance of inconsistent
changes in gene expression values between the two MPL
concentrations: after 24 h exposure, pgp-11 showed an in-
creased expression level in response to MPL250 μg/ml (8.8-
fold), compared to a decrease in expression in response
toMPL2.5 μg/ml (1.6-fold) (compare Fig. 1c, f ).
Transcriptional response of ABC transporters to MPL
exposure in WAL larvae
The effects of MPL on transcription of ABC transporters in
WAL larvae are shown in Fig. 2 and Table 1 (ANOVA:
2.5 μg/ml, 3 h F(16,32) = 1.793, P = 0.0782, 6 h F(16,32) =
1.057, P = 0.4305, 24 h F(16,32) = 7.058, P < 0.0001;
250 μg/ml, 3 h F(16,32) = 5.789, P < 0.0001, 6 h F(16,32) =
4.831, P < 0.0001, 24 h F(16,32) = 71.99, P < 0.0001).
Exposure of WAL L3 to MPL2.5 μg/ml did not result in
significant upregulation of any of the transporter genes
(Fig. 2a, c). On the other hand, there were a number of
instances of significant downregulation at 3 and 24 h
(Fig. 2a, c). The magnitude of these decreases at 3 h
were as follows: 1.4-fold for pgp-1 and abcf-1 (P = 0.02; P =
0.04), and 1.3-fold for pgp-10 and haf-6 (P = 0.04; P = 0.03).
These decreases in gene transcription were short lived as
they had returned to levels equivalent to controls by 6 h
exposure (Fig. 2b). Following 24 h MPL2.5 μg/ml exposure,
pgp-2 (1.4-fold; P = 0.02), pgp-9.1 (1.6-fold; P = 0.002), pgp-
11 (2.6-fold; P < 0.0001) and abcf-1 (1.4-fold; P = 0.03)
showed significantly decreased transcription relative to
DMSO controls (Fig. 2c).
In contrast, exposure of WAL larvae to MPL250 μg/ml
for 3 h resulted in significantly increased transcription of
five P-gp genes and the haf-6 (Fig. 2d) (Table 1). Of note
here was the greater number of upregulated genes in
WAL compared to Kirby isolate following 3 h exposure
to MPL (compare Figs. 1d and 2d). The magnitudes of
the increases for WAL were as follows: 7.9-fold for pgp-
2 (P = 0.002), 8.4-fold for pgp-9.1 (P = 0.002), 11.7-fold
for pgp-11 (P = 0.0004), 9.4-fold for pgp-12 (P = 0.001),
12.2-fold for pgp-14 (P = 0.0002) and 20.5-fold for haf-6
(P = 0.0007). There were no instances of significant
downregulation at the 3 h and 6 h time points. The
increased transcription of pgp-2, pgp-9.1 and haf-6 genes
observed at 3 h was short lived as it had returned to
DMSO control levels by the 6 h time point for these
Fig. 1 Effect of monepantel on transcription patterns of ABC transporter genes in Haemonchus contortus Kirby isolate. Larvae were exposed to
MPL at two concentrations for a range of time periods: MPL2.5μg/ml (a at 3 h, b at 6 h and c at 24 h) or MPL250μg/ml (d at 3 h, e at 6 h and f at
24 h). Y-axis shows fold-change in gene expression levels in drug-treated larvae vs DMSO-treated controls. Data shown as mean ± standard error
of the mean (SEM), n = 3 separate experiments each with four technical replicates. Significant differences in gene transcription levels are indicated
by * (P < 0.05)
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three genes (Fig. 2d, e) (Table 1). In contrast, the upreg-
ulation of pgp-11, pgp-12 and pgp-14 was maintained at
the 6 h time point; pgp-11 7.4-fold (P = 0.0007), pgp-
12 8.2-fold (P = 0.001), and pgp-14 5.5-fold (P = 0.002).
These increases also occurred at the 24 h time point;
pgp-11 6.9-fold (P < 0.0001), pgp-12 2.9-fold (P < 0.0001)
and pgp-14 2.6-fold (P < 0.0001). For each of these genes,
the magnitude of fold change in expression relative to
controls decreased over the sequential time points from
3 to 24 h (for example from 12.2-fold to 2.6-fold for
pgp-14). Following 24 h exposure to MPL, transcription
of pgp-9.3, pgp-10, pgp-16 and mrp-5 were significantly
downregulated at levels of 1.4-fold (P = 0.003), 1.7-fold
(P < 0.0001), 1.3-fold (P = 0.02) and 1.3-fold (P = 0.03),
respectively (Fig. 2f ).
There were several instances of inconsistent changes
in gene expression values between the two MPL concen-
trations, with expression reduced at the lower MPL con-
centration and increased at the higher concentration for
haf-6 at 3 h, as well as pgp-2 and pgp-11 at 24 h. As de-
scribed above, this difference in response to the two
MPL concentrations was also observed for Kirby with
pgp-11 at 24 h.
Overall, for WAL larvae, the most marked effects of
MPL exposure were the significant upregulation of a
number of transporter genes at the 3 h time point for
MPL250 μg/ml, and the sustained nature of these increases
for pgp-11, pgp-12 and pgp-14, alongside the absence of
any upregulation by MPL2.5 μg/ml. This pattern was very
similar to that seen with Kirby larvae, with the exception
of the unchanged expression for pgp-11 at 3 h for the
Kirby larvae (Table 1).
The stability of the observed transcriptional
changes was examined by exposing WAL L3 to
MPL250 μg/ml for 3 h, rinsing the larvae in water, and
then maintaining them in the absence of drug for a
further 24 h before recovery for analysis of ABC
transporter gene expression patterns. Figure 3 shows
that of the gene expression changes measured in
WAL L3 after 3 h exposure to MPL (from Fig. 2d),
only the increased expression of pgp-11 was main-
tained in these larvae after 24 h in the absence of
any drug.
Over this period, the fold increase in this gene in
MPL-treated larvae compared to controls decreased
from 11.7-fold (P = 0.0004) to 3-fold (P = 0.004) (com-
pare Figs. 2d and 3). There was some variability in
the expression patterns of pgp-9.1 (as indicated by the
large SEM bars), however, statistical analysis across
the three replicate experiments showed that the ex-
pression level of this gene was not significantly differ-
ent to controls.
Phenotypic characterization of the MPL-treated larvae
Rhodamine-123 efflux assay
The functional consequences of exposure to MPL
were evaluated by measuring the ability of MPL pre-
treated Kirby and WAL L3 to efflux the fluorescent
dye R-123 (Fig. 4) (ANOVA: Kirby 3 h F(2,4) = 12.51,
P = 0.0190, 6 h F(2,4) = 6.004, P = 0.0624; WAL 3 h
F(2,4) = 4.148, P = 0.1058, 6 h F(2,4) = 9.691, P = 0.0293).
Exposure of Kirby L3 to MPL2.5 μg/ml and MPL250 μg/
ml for 3 h resulted in increased R-123 efflux com-
pared to controls (1.2-fold, P = 0.009, and 1.3-fold, P
= 0.017, respectively) (Fig. 4a). By 6 h, increased ef-
flux was still recorded for worms exposed to MPL250
μg/ml (1.2-fold, P = 0.027), whereas the efflux had
returned to control levels for the MPL2.5 μg/ml treat-
ment (Fig. 4b). For WAL larvae, increased efflux was ob-
served for MPL250 μg/ml at both time points (1.2-fold, P =
0.045 at 3 h, and 1.2-fold, P = 0.011 at 6 h), while efflux
was unchanged for the MPL2.5 μg/ml treatment at both
time points (Fig. 4c, d).
The levels of R-123 efflux were equivalent in Kirby
and WAL L3 in the absence of any drug exposure
(DMSO-treated) at both 3 and 6 h (P = 0.24 and P = 0.12)
(data not shown).
Table 1 Relative transcription levels of ABC transporter genes in
the 250 μg/ml MPL-treated Kirby and WAL larvae compared to
DMSO-treated controls. Significant (P < 0.05) increases or decreases
in transcription in the MPL-treated larvae compared to the
DMSO-treated larvae are indicated by * and #, respectively
Gene Kirby WAL
3 h 6 h 24 h 3 h 6 h 24 h
Pgp 1 0.39 1.4 1.0 2.5 0.77 0.98
Pgp 2 0.29# 2.6 2.2* 7.9* 2.1 2.2*
Pgp 3 0.94 1.8 1.1 2.7 0.68 1.2
Pgp 9.1 0.46 1.4 1.1 8.4* 1.2 1.0
Pgp 9.2 1.9 1.4 1.2 1.8 0.97 0.95
Pgp 9.3 1.2 1.0 0.84 1.0 1.4 0.72#
Pgp 10 0.41 0.35 0.62# 1.8 0.76 0.59#
Pgp 11 0.69 2.3 8.8* 11.7* 7.4* 6.9*
Pgp 12 5.4* 9.1* 2.3* 9.4* 8.2* 2.9*
Pgp 14 8.7* 4.6* 2.4* 12.2* 5.5* 2.6*
Pgp 16 1.3 1.1 0.52# 0.51 1.0 0.79#
MRP 1 1.01 1.9 1.8* 1.2 1.0 1.5*
MRP 5 1.2 0.9 0.73# 1.4 0.88 0.79#
ABCF 1 0.43 0.8 0.97 2.0 0.87 0.92
ABCF 2 1.1 0.97 1.1 2.1 1.0 1.0
HAF-6 0.58# 0.54 0.94 20.5* 0.85 1.0
# denotes decreased gene transcription following MPL exposure compared to
DMSO-treated controls
* denotes increased gene transcription following MPL exposure compared to
DMSO-treated controls
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Larval migration assay
The functional consequences of changes in transcription
of transporter genes following exposure to the two
concentrations of MPL were further examined using mi-
gration assays. Following 3 h exposure to MPL2.5 μg/ml,
there were no significant changes to the tolerance of
both Kirby and WAL L3to IVM and LEV, both in terms
of the IVM IC50 values and the percent migration at the
dose-response plateau at the high IVM concentrations
(data not shown). Given, this lack of effect of 3 h exposure
to MPL2.5 μg/ml, alongside the absence of gene expression
changes in 6 h MPL2.5 μg/ml-treated Kirby and WAL larvae
(Figs. 1b, 2b), we did not measure the response of 6 h
MPL2.5 μg/ml pre-exposed larvae to IVM or LEV.
In contrast to the 3 h MPL2.5 μg/ml data, exposure to
MPL250 μg/ml for 3 or 6 h resulted in significant changes
in the IVM dose response curves compared to larvae
pre-treated with DMSO alone (Fig. 5). The MPL250 μg/
ml-treated larvae showed a greater ability to migrate at
high IVM concentrations compared to control larvae.
This was demonstrated in two ways, first, the signifi-
cantly higher IVM dose-response plateau for MPL pre-
treated larvae compared to controls for WAL larvae at
3 h, and both isolates after 6 h pre-treatment (WAL 3 h
33.79 vs 17.60 %; Kirby 6 h 27.08 vs 4.27 %; WAL 6 h
Fig. 2 Effect of monepantel on transcription patterns of ABC transporter genes in Haemonchus contortus WAL isolate. Larvae were exposed to
MPL at two concentrations for a range of time periods: MPL2.5μg/ml (a at 3 h, b at 6 h and c at 24 h) or MPL250μg/ml (d at 3 h, e at 6 h and f at
24 h). Y-axis shows fold-change in gene expression levels in drug-treated larvae vs DMSO-treated controls. Data shown as mean ± standard error
of the mean (SEM), n = 3 separate experiments each with four technical replicates. Significant differences in gene transcription levels are indicated
by * (P < 0.05)
Fig. 3 Stability of transporter gene transcription following 3 h
pre-exposure of WAL larvae to monepantel. Larvae were exposed
to MPL250μg/ml for 3 h, rinsed in water and maintained for 24 h
with no drug. Y-axis shows fold-change in gene expression levels
in drug-treated vs DMSO-treated larvae. Data shown as mean ±
standard error of the mean (SEM), n = 3 separate experiments each
with four technical replicates. Significant differences in transcription
levels are indicated by * (P < 0.05)
Raza et al. Parasites & Vectors  (2016) 9:522 Page 7 of 13
37.05 vs 16.75 %) (Table 2); and secondly, the t-test ana-
lysis showing that the percent migration at the highest
IVM concentrations was consistently greater (P < 0.05)
than the percent migration at the same IVM concentra-
tion for controls (Fig. 5).
In contrast to these changes in response to the highest
IVM concentrations, the response of the remaining
worm population did not change significantly, as shown
by equivalent IC50 values, and a lack of statistical differ-
ences in percent migration at individual IVM concentra-
tions (t-test analysis) (Table 2, Fig. 5). That is, the IVM
tolerance was only observed in a component of the
worm population. The only exception to this, in terms
of the t-test analysis, was the decreased migration for
MPL treated larvae at an IVM concentration of 0.2 μg/
ml for WAL larvae (Fig. 5c). There were no significant
Fig. 4 Rhodamine efflux from larvae following monepantel pre-exposure. R-123 efflux was measured after exposure of L3 stage larvae to
MPL250μg/ml or MPL2.5μg/ml, compared to DMSO-treated controls; Kirby isolate: a at 3 h and b at 6 h; WAL isolate: c at 3 h and d at 6 h. Significant
increase in R-123 efflux compared to controls is indicated by * (P < 0.05). The columns represent mean ± standard error of the mean (SEM), n = 6
(pooled data from three separate experiments, each with assays in duplicate)
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changes in LEV IC50 values following exposure of Kirby
and WAL larvae to MPL250 μg/ml (see Additional file 2:
Figure S1; Additional file 3: Table S2).
WAL larvae that had been exposed to MPL250 μg/ml for
3 h, then washed and held in water for a further 24 h,
before being exposed to a range of IVM concentrations
in LMAs, showed a similar pattern of IVM tolerance to
that described above (Fig. 6). The IVM dose-response
plateau was increased significantly (from 14.6 to 31.8 %),
the t-test analysis showed significant differences at the
four highest IVM concentrations, and there was no
change in the IC50 (Fig. 6a). There were no significant
changes in LEV IC50 values for these MPL-treated larvae
compared to DMSO controls (Fig. 6b).
Fig. 5 IVM sensitivity in Kirby and WAL L3 stage larvae following monepantel pre-exposure. Sensitivity to IVM was measured using migration
assays following pre-exposure to MPL250μg/ml in Kirby (a after 3 h pre-exposure and b after 6 h pre-exposure) and WAL (c after 3 h pre-exposure
and d after 6 h pre-exposure) L3 stage larvae, compared to L3 pre-exposed to DMSO only. DMSO pre-exposure shown with solid lines and closed
symbols, MPL pre-exposure shown with dashed lines and open symbols. The data points marked with * show significant differences (P < 0.05) in
percent migration between MPL- and DMSO- pre-exposure groups (t-test). Each data point represents mean ± standard error of the mean (SEM),
n = 9 (pooled data from three experiments, each with assays in triplicate)
Table 2 Response of Haemonchus contortus larvae to ivermectin following pre-exposure to monepantel
Pre-exposure period Isolate Drug exposure Ivermectin dose-response
IC50 Dose-response plateau
Drug conc.a (μg/ml) 95 % CI Drug/DMSOa,b Migrationc (%) 95 % CI Drug/ DMSOc,d
3 h Kirby DMSO 1.6 1.3–1.9 – 7.3 2.3–12.3 –
MPL 2.5 1.6–3.8 1.5 18.3 7.5–29.2 2.5
WAL DMSO 4.0 3.5–4.6 – 17.6 12.7–22.5 –
MPL 6.1 4.2–8.9 1.5 33.8* 25.8–41.8 1.9*
6 h Kirby DMSO 1.4 1.2–1.7 – 4.3 -0.06–8.6 –
MPL 0.9 0.5–1.5 0.6 27.1* 18.1–36.1 6.3*
WAL DMSO 2.8 2.4–3.3 – 16.8 10.9–22.6 –
MPL 2.5 1.1–5.6 1.03 37.1* 24.0–50.1 2.2*
aWithin either the 3 or 6 h pre-exposure data sets, * denotes that the IC50 following pre-exposure to anthelmintic was significantly higher than the IC50 following
pre-exposure to DMSO, as determined by non-overlap of 95 % confidence intervals
bDrug / DMSO = IC50 for IVM following pre-exposure to MPL/ IC50 for IVM following pre-exposure to DMSO
cWithin either the 3 or 6 h pre-exposure data sets, * denotes that L3 migration at the dose-response plateau (%) following pre-exposure to MPL was significantly
higher than L3 migration (%) following pre-exposure to DMSO, as determined by non-overlap of 95 % confidence intervals
dDrug / DMSO = L3 migration (%) for IVM following pre-exposure to MPL/ L3 migration (%) for IVM following pre-exposure to DMSO
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Discussion
In this study, we have demonstrated that exposure of H.
contortus L3 to a high concentration of MPL (250 μg/ml)
results in increased transcription of a number of ABC-
transporter genes. Furthermore, exposure to MPL at this
concentration results in greater efflux of R-123 from the
L3, as well as increased tolerance to IVM in a proportion
of the larval population. In contrast, pre-exposure to a
100-fold lower concentration of the compound (2.5 μg/
ml) only resulted in a single instance of low-level upregu-
lation of a transporter gene (pgp-11), an increase in R-123
efflux in only one out of four isolate/ time point instances,
and did not result in any IVM tolerance in subsequent mi-
gration assays. Hence, the effects of MPL on gene tran-
scription, R-123 efflux and subsequent IVM tolerance
were dependent on the concentration of the compound to
which the larvae were exposed. This study is the first, to
our knowledge, to indicate an interaction between MPL
and ABC transporters in nematodes. However, our data
describe the effects of MPL on the regulation of ABC
transporter gene expression rather than a direct effect of
the drug on the transporter proteins themselves. The
demonstration of functional consequences of the gene
transcription increases, in terms of R-123 efflux and IVM
tolerance, indicates that the transcription increases most
likely result in increased transporter protein activity to-
wards R-123 and IVM. Hence, the present study provides
evidence of an interaction of MPL with the regulatory
mechanism for ABC transporter gene expression, and
subsequent protein synthesis, rather than evidence as to
whether MPL itself is a substrate for the transporters.
As described above, the transporter gene upregulation/
R-123 efflux / IVM tolerance relationships were only ob-
served at the high MPL concentration. This concentra-
tion was well above the levels that an adult worm would
encounter in the abomasum of a sheep, as measured by
Lifschitz et al. [21] to be 2–4 μg/g of abomasal content
48 h after administration of the drug. On the other hand,
the lower concentration of MPL used in the present
study, which was selected based on it approximating this
in vivo concentration range, resulted in only one in-
stance of transporter gene upregulation, and did not re-
sult in any IVM tolerance. It is clear that while the
present study indicates an interaction between MPL at
250 μg/ml and the regulatory mechanism for ABC trans-
porter transcription in H. contortus, it does not provide
evidence for such a role in vivo. Further experiments
would be needed to determine if MPL interacts with
transporters in adult worms in vivo.
While the patterns of upregulation in Kirby and WAL
L3s were quite similar at 6 and 24 h time points, the
WAL larvae showed a much greater level of upregula-
tion (in terms of fold increases as well as the number of
transporters affected) at the 3 h time point compared to
Kirby (compare Figs. 2d and 1d). Our earlier study,
reported the upregulation of ABC transporters in the
WAL isolate after exposure to IVM and LEV, alongside
no changes in Kirby at the 3 and 6 h time points exam-
ined in that study [13]. This suggested that the rapid
upregulation in response to these two drugs in the WAL
isolate may be a component of the resistance shown by
this isolate to the two anthelmintics. WAL and Kirby are
both susceptible to MPL [20], having been isolated from
the field before the use of this drug. The present study
therefore indicates that this increased responsiveness of
WAL larvae also occurs with respect to its response to
drugs to which it is not resistant, and to which it has
never been exposed. Thus, if the rapid upregulation
following exposure to IVM and LEV is a component of
the resistance shown towards these drugs as suggested
by Raza et al. [13], then the present study suggests that
this increased responsiveness may be quite general in
Fig. 6 Stability of IVM tolerance in WAL L3 stage larvae pre-treated with monepantel. Sensitivity of WAL L3 stage larvae to IVM (a) or LEV (b)
was measured using migration assays following pre-exposure for 3 h to MPL250μg/ml, followed by 24 h in water only, compared to L3 exposed to
DMSO for 3 h, followed by water for 24 h. DMSO pre-exposure shown with solid lines and closed symbols, MPL pre-exposure shown with dashed
lines and open symbols. The data points marked with * show significant differences (P < 0.05) in percent migration between MPL- and DMSO-
pre-exposure groups (t-test). Each data point represents mean ± standard error of the mean (SEM), n = 9 (pooled data from three experiments,
each with assays in triplicate)
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nature, extending to xenobiotics beyond the anthelmintics
that were involved in the original resistance-selection
process in the field. Importantly though, while WAL lar-
vae respond more rapidly and to a greater extent than
Kirby to MPL under our experimental conditions, the two
isolates show equivalent sensitivities to the drug in larval
development assays [20]. Hence, there is no evidence yet
that the increased responsiveness in ABC transporters
seen in WAL in the present study provides any subse-
quent protection against MPL; only protection against
IVM has been suggested by our data.
The pattern of transcription changes over the time
course of the present experiments was quite different to
that observed in our earlier experiments with IVM and
LEV [13]. In this earlier study, exposure to either of the
two anthelmintics resulted in ABC transporter transcrip-
tion increases in WAL larvae at the 3 h time point,
however, these had returned to control levels either
completely (for IVM) or almost completely (with the
exception of one gene for LEV) by 6 h. In contrast, in
the present study, the upregulation response was sus-
tained over the 24 h time period of the experiments.
This difference between the two studies is most likely
due to the relative concentrations of the drugs used. The
concentrations were chosen on the basis of being the
highest concentrations that could be examined without
effecting the ability of the larvae to migrate in LMAs in
the second phase of the drug-exposure experiments,
thereby allowing for the consequences of drug exposure
to be assessed using LMAs. As MPL is far less potent as an
inhibitor of larval migration than IVM and LEV [20, 22],
the higher of the two concentrations used in the present
study was much higher than those used previously by
Raza et al. [13] for IVM and LEV (250 μg/ml com-
pared to 0.2–0.8 μg/ml).
It has been suggested that nematodes may use gene
upregulation as a mechanism to counter the toxic effects
of anthelmintics [23]. There is considerable evidence that
anthelmintics act as substrates of ABC transporters and
have inducing effects on the expression levels of trans-
porter genes in nematodes and mammals [11, 24, 25].
However, nematode transporter genes do not show a
consistent pattern of upregulation following exposure to
anthelmintics. Significantly increased transcription of
several P-gp genes was reported in wild-type and IVM-
resistant isolates of Caenorhabditis elegans post-exposure
to moxidectin [14]. On the other hand, exposure of the
same isolates of C. elegans to IVM resulted in upregula-
tion of a different set of P-gp genes [8]. Some studies on
parasitic nematodes have reported increases in transcrip-
tion of transporter genes following in vitro and in vivo
exposure to IVM [12, 16, 26], whereas no transcriptional
changes were observed in IVM-resistant H. contortus and
Cooperia oncophora worms collected from animals treated
with IVM compared to the worms collected from
untreated control animals [27, 28].
We also examined the stability of the observed transcrip-
tional changes by exposing WAL L3 to MPL250 μg/ml for
3 h, rinsing the larvae in water, and then maintaining them
in the absence of drug for a further 24 h. We found that
only the transcription level of pgp-11remained at signifi-
cantly higher levels compared to control larvae. We also
observed increased tolerance to IVM in a proportion of the
WAL larval population 24 h after the removal of MPL fol-
lowing a 3 h pre-treatment period (see Fig. 6). There is very
little information available on the time course of ABC
transporter gene expression patterns after the removal of
the inducing agent. Fardel et al. [29] reported that expres-
sion of P-gp (mdr-1) in rat liver epithelial cells, as measured
by qPCR and Western blotting, was significantly higher fol-
lowing exposure to 3-methylcholanthene for 24 h, with a
return to almost basal levels 72 h after removal of the indu-
cing agent. The sustained upregulation of pgp-11 alone after
removal of the MPL in the present study suggests that this
specific ABC transporter may play a more important role
in interaction with MPL in WAL larvae than the other
transporters. On the other hand, the maintenance of IVM
tolerance 24 h after removal of the MPL cannot be linked
specifically to the sustained upregulation of pgp-11 as the
tolerance may be due to increased efflux activity of other
ABC transporter proteins that may be present at higher
levels as a result of the earlier period of gene upregulation
(from Fig. 2d).
The presence of plateaus in IVM dose-response curves at
the highest IVM concentrations was most likely due to the
short nature of both the drug incubation and migration
phases (30 min for each) of the LMA compared to the 48
and 24 h incubation/migration periods usually used for this
assay [22]. As described earlier, the assay was modified to
avoid any effects of the drugs in possibly inducing tran-
scription of the transporter genes during long (24 and 48 h)
incubation periods. These plateaus were likely due to the
subsequent inability of IVM to inhibit migration completely
in all larvae in the short 30 min time frame, and were also
reported in our earlier study [13]. Tolerance to IVM only
occurred in the proportion of the population represented
by the dose-response plateau, as the IC50 in the remainder
of the population was unchanged compared to DMSO pre-
treated L3 (see Table 2). A proportion of the larvae were
clearly better equipped to tolerate IVM following MPL250
μg/ml exposure (as indicated by percent migration at plateau
and t-test analysis), while the remainder of the population
showed no change in IVM sensitivity. Although we have no
direct evidence for a role of transporters in the observed
IVM tolerance, the known role for ABC transporters in
IVM tolerance [9] in parallel with our gene upregula-
tion/R-123 efflux increases/IVM tolerance observations
in the present study, suggest that the MPL-induced
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transporters were able to subsequently provide protection
against IVM in a proportion of the larval population in
our experiments. Hence, our data demonstrate the poten-
tial role of the transporters in responding to exposure to
an anthelmintic, and, in so doing, provide protection
against structurally-unrelated compounds. The fact that
IVM tolerance was only observed in a proportion of the
worm population following MPL pre-exposure may indi-
cate a degree of heterogeneity in the effect of MPL expos-
ure on ABC transporter gene expression across the worm
population, as was also suggested by the similar IVM
dose-response plateau versus IC50 effects following pre-
exposure to IVM or LEV in our previous study [13].
There were no significant changes in LEV dose-response
experiments following exposure to MPL at both concentra-
tions, suggesting that the transporters induced in response
to MPL exposure are able to subsequently provide protec-
tion against IVM but not LEV. Raza et al. [13] previously
showed that pre-exposure to IVM or LEV resulted in toler-
ance to IVM, alongside no change in the response to LEV.
Hence, the earlier and present studies provide evidence to
suggest that IVM may be a better substrate than LEV for H.
contortus ABC transporters, as has been reported for
mammalian P-gps [30].
Conclusions
In conclusion, the present study has shown that expos-
ure to a high concentration of MPL increases the tran-
scription of multiple ABC transporter genes in two
MPL-susceptible isolates of H. contortus. The most sig-
nificant interactions were for pgp-11, pgp-12 and pgp-14,
based on (i) the magnitude of the transcriptional re-
sponse, (ii) the occurrence of this response across mul-
tiple time points, (iii) the consistency of the response
between the two isolates, and (iv) the stability of the re-
sponse upon removal of the MPL (applicable to pgp-11
only). The subsequent ability of a proportion of MPL-
exposed L3 to tolerate higher levels of IVM provides fur-
ther evidence that ABC transporters play an important
role in protection of worms against this anthelmintic,
and illustrates the ability of ABC transporters to interact
with different chemical entities. However, while the
study describes interactions of ABC transporters with a
high concentration of MPL in vitro, the effects of MPL
on efflux pathways in vivo remains to be determined.
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